THERANOSTICS CENTRE OF EXCELLENCE
Advancing Theranostics Through Knowledge & Collaboration
By helping clinicians identify disease, assess treatment suitability and monitor response over time, theranostics is contributing to a new era of precision medicine. Already used in clinical practice for selected patients with prostate cancer, neuroendocrine tumours, thyroid cancer and non-melanoma skin cancer, theranostics continues to evolve through ongoing research and innovation.
Whether you are a patient, caregiver, healthcare professional or simply looking to learn more, this hub has been developed to provide clear, balanced and evidence-informed information about theranostics and its role in modern healthcare.
What is Theranostics?
The term "theranostics" combines two words:
Therapy and Diagnostics
Together, they describe an approach that uses related technologies to both identify and treat disease.
In many cases, specialised nuclear imaging is first used to determine whether a disease expresses a particular biological target. If that target is present, a corresponding radiotherapy may then be used to deliver treatment directly to the affected cells.
This approach helps support more personalised treatment decisions and enables clinicians to better understand how a disease is behaving before therapy begins.
How Theranostics Works
Learn more about the patient journey, imaging, treatment planning, targeted therapies and ongoing monitoring.
UNDERSTANDING THERANOSTICS
Precision Oncology Explained
Precision oncology is an approach to cancer care that aims to tailor treatment according to the individual characteristics of a patient's disease.
Rather than relying solely on where a cancer originates in the body, precision oncology considers factors such as molecular markers, genetic characteristics and biological targets that may influence treatment decisions.
Theranostics plays an important role within precision oncology by helping clinicians visualise these targets and determine whether a patient may be suitable for specific treatment approaches.
As precision medicine continues to advance, theranostics is becoming an increasingly important component of personalised cancer care.
Why Theranostics Matters
A future where every person who may benefit from theranostics has access to Healthcare is moving towards a future where treatment is increasingly tailored to the individual.
Theranostics supports this shift by helping clinicians better understand disease, guide treatment decisions and monitor response over time. By combining diagnostic imaging with targeted therapies, theranostics offers a more personalised approach that may improve treatment selection and provide valuable information throughout the patient journey.
For many patients, theranostics represents an opportunity to move beyond traditional one-size-fits-all approaches and towards care that is informed by the unique characteristics of their disease.
Theranostics vs Traditional Cancer Treatments
Traditional cancer treatments such as surgery, chemotherapy and radiation therapy continue to play an essential role in patient care.
Theranostics does not replace these treatments. Instead, it complements existing treatment pathways by providing additional information that can help guide clinical decision-making.
One of the distinguishing features of theranostics is its ability to combine diagnistics and treatment around a shared biological target. This allows clinicians to gain insights into disease characteristics before treatment begins and, in some cases, deliver therapy directly to targeted cells.
The most appropriate treatment approach will always depend on the individual patient, their disease and recommendations from their healthcare team.
Radioligand Therapy Explained
Radioligand therapy is one example of how theranostics can be used in clinical practice.
A radioligand consists of two key components:
• A targeting molecule that seeks out specific cells.
• A radioactive component designed to deliver therapy.
Once administered, the targeting molecule helps guide the therapy towards cells that express the relevant biological target.
Radioligand therapies are currently used in selected clinical settings and continue to be investigated across a growing number of disease areas.
Nuclear Medicine in Cancer Care
Theranostics is closely linked to the field of nuclear medicine.
Nuclear medicine uses small amounts of radioactive substances for diagnostic imaging, disease assessment and, in some cases, treatment.
These technologies allow clinicians to visualise biological processes occurring within the body and can provide information that may not be available through conventional imaging alone.
Advances in nuclear medicine have played a critical role in the development of theranostics and continue to drive innovation across precision healthcare.
KEY TAKEAWAYS
Your Trusted Theranostics Knowledge Hub
-
Theranostics combines diagnostics and therapy to support personalised healthcare.
-
It plays an increasingly important role in precision oncology.
-
Theranostics is already used in clinical practice for selected patients with several cancer types.
-
Radioligand therapy is one example of a theranostic treatment approach.
-
Nuclear medicine forms an important foundation for many theranostic technologies.
-
Research continues to expand the potential applications of theranostics across additional diseases and clinical settings.
Leading Knowledge. Connecting the Theranostics Community.
Continue Exploring
Medical Disclaimer
The information provided on this website is intended for educational purposes only and should not be considered medical advice. Treatment decisions should always be made in consultation with qualified healthcare professionals who can consider individual circumstances and clinical needs.